Evidence-based medicine

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

Monday, October 18, 2021 - 1:00pm

If the Election Deadline is delayed or extended for any reason, Bioventus and Misonix will promptly announce the delay and, when determined, the rescheduled Election Deadline.

Key Points: 
  • If the Election Deadline is delayed or extended for any reason, Bioventus and Misonix will promptly announce the delay and, when determined, the rescheduled Election Deadline.
  • Record holders of Misonix common stock should have already received a Letter of Election and Transmittal, which permits the stockholder to make an election as to the type of merger consideration.
  • Misonix stockholders who have no received these instructions are encouraged to contact the bank, brokerage firm or other nominee holding their shares of Misonix common stock as soon as possible.
  • Readers should also carefully review the risk factors described in other documents that Bioventus and Misonix file from time to time with the Commission.

MemorialCare Earns National Recognition for Efforts to Improve Cardiovascular, Diabetes and Stroke Treatment

Thursday, October 14, 2021 - 9:36pm

MemorialCare has also received four American Heart Association outpatient program awards in recognition for their commitment to reducing the risk of heart disease and stroke through improving type 2 diabetes and blood pressure management.

Key Points: 
  • MemorialCare has also received four American Heart Association outpatient program awards in recognition for their commitment to reducing the risk of heart disease and stroke through improving type 2 diabetes and blood pressure management.
  • Nearly half of all adults in the U.S. have experienced some form of cardiovascular disease including heart attack, stroke and heart failure.
  • The American Heart Association's Get With The Guidelines programs help reduce barriers to prompt treatment for cardiovascular events.
  • "The Get with the Guidelines programs help put proven knowledge and guidelines to work on a daily basis to improve outcomes for cardiovascular and stroke patients."

ECRI CEO Marcus Schabacker Named 2021 Healthcare Leader

Wednesday, October 13, 2021 - 6:16pm

PLYMOUTH MEETING, Pa., Oct. 13, 2021 /PRNewswire/ -- Marcus Schabacker, MD, PhD, president and chief executive officer of ECRI, an independent nonprofit organization that improves the safety, quality, and cost-effectiveness of healthcare, has been honored by the Philadelphia Business Journal with a Leaders in Healthcare 2021 Award.

Key Points: 
  • PLYMOUTH MEETING, Pa., Oct. 13, 2021 /PRNewswire/ -- Marcus Schabacker, MD, PhD, president and chief executive officer of ECRI, an independent nonprofit organization that improves the safety, quality, and cost-effectiveness of healthcare, has been honored by the Philadelphia Business Journal with a Leaders in Healthcare 2021 Award.
  • Schabacker took important steps in early 2020 to prepare the healthcare community for what would become a global pandemic.
  • For more information about Marcus Schabacker and ECRI's role in guiding the healthcare community and the public with evidence-based guidance, download the ECRI COVID-19 Journey .
  • Philadelphia Business Journal honors @SchabackerECRI, CEO of @ECRI_Org with Leaders in Healthcare 2021 Award
    ECRI is an independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings.

Dr. Fred Simon M.D. joins Nevada Governor race

Monday, October 11, 2021 - 4:49pm

GARDNERVILLE, Nev., Oct. 11, 2021 /PRNewswire/ -- Dr. Fred Simon, a trauma surgeon and businessman from Gardnerville, Nevada has announced his intention to run for Governor of Nevada as a Republican.

Key Points: 
  • GARDNERVILLE, Nev., Oct. 11, 2021 /PRNewswire/ -- Dr. Fred Simon, a trauma surgeon and businessman from Gardnerville, Nevada has announced his intention to run for Governor of Nevada as a Republican.
  • "Nevada needs expert medical and executive leadership to lead us out of this Covid crisis", says Dr. Simon.
  • "We have a Governor who is practicing medicine without a license and Nevada's citizens and our children are being harmed," says Dr. Simon.
  • "I'll bring new, effective, executive leadership to deliver Voter ID, School Choice and more healthcare options to all Nevadans."

Ipsen appoints Mari Scheiffele as EVP and President, Specialty Care International

Monday, October 11, 2021 - 6:00am
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211010005020/en/
    Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Mari Scheiffele as EVP and President, Specialty Care International, effective November 1st 2021.
  • Mari also brings valuable capabilities in transformation which she built over the course of her previous roles at Novartis and McKinsey.
  • In addition to her depth in Oncology, Mari has worked in other specialty care environments such as ophthalmology, neuroscience and immunology.
  • Im delighted to be joining Ipsen at such an exciting time, said Mari Scheiffele.

Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction

Friday, October 8, 2021 - 4:01pm

BOAO, China, Oct. 8, 2021 /PRNewswire/ -- On September 30, 2021 (Hainan-Bo'ao), Hongkong WinhealthPharma Group (Winhealth Pharma) and the China Alliance for Rare Disease (CARD) officially signed a five-year strategic collaboration agreement.

Key Points: 
  • BOAO, China, Oct. 8, 2021 /PRNewswire/ -- On September 30, 2021 (Hainan-Bo'ao), Hongkong WinhealthPharma Group (Winhealth Pharma) and the China Alliance for Rare Disease (CARD) officially signed a five-year strategic collaboration agreement.
  • The cooperation involved rare disease registration and research, development of single disease diagnosis and treatment guidelines and regulations, doctor training & patient guide, etc.
  • Winhealth Pharmawill make efforts together with CARD to promote comprehensive capacity building in clinical diagnosis and disease management focusing on improvement on rare diseases prevention and treatment.
  • With the unique two-wheeled business mode, WinhealthPharmawill boost the global and innovative drug accessibility for rare diseases, and the two-wheeled business mode includes both the License-in and Managed-access.

Legend Capital leads ForQaly Medical's Series B financing

Friday, October 8, 2021 - 7:13am

Recently, it completed its Series B fundraising led by Legend Capital, followed by CD Capital, SAIF Partners, Chengwei Chuangban and Co-win Ventures.

Key Points: 
  • Recently, it completed its Series B fundraising led by Legend Capital, followed by CD Capital, SAIF Partners, Chengwei Chuangban and Co-win Ventures.
  • Existing investors Lilly Asia Ventures and Kaitai Capital also participated in the funding round.
  • Joe Zhou, the Managing Director of Legend Capital, said: "VAD, especially the interventional one, has a huge market prospect in China.
  • We are glad to partner with ForQaly Medical and will establish a long-term cooperation with the company.

ECRI Announces Winners of 2021 Healthcare Supply Chain Award

Wednesday, October 6, 2021 - 3:02pm

Mount Sinai Medical Center,Miami Beach, FL*

Key Points: 
  • Mount Sinai Medical Center,Miami Beach, FL*
    University of Miami Health System,Miami, FL**
    The Healthcare Supply Chain Achievement Award recognizes members of ECRI's portfolio of supply chain services who demonstrate exemplary utilization of services across the procurement lifecycle, including budgeting, benchmarking, technology assessment, and strategic development.
  • More than 3,000 U.S. hospitals and health systems are members of ECRI's strategic sourcing and supply chain programs.
  • To learn more about ECRI's Supply Chain Achievement Award winners, visit www.ecri.org , e-mail communications@ecri.org , or call (610) 825-6000, ext.
  • ECRI is an independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings.

Allied OMS Partners With Facial & Oral Surgery Associates to Deliver Exceptional Care & Clinical Outcomes to More Patients in Texas

Monday, October 4, 2021 - 4:00pm

"We're delighted to partner with the team at Facial & Oral Surgery Associates, who is known for delivering exceptional oral and maxillofacial surgical care to patients using the most advanced technologies in dentistry and medicine," said Dan Hosler, CEO of Allied OMS.

Key Points: 
  • "We're delighted to partner with the team at Facial & Oral Surgery Associates, who is known for delivering exceptional oral and maxillofacial surgical care to patients using the most advanced technologies in dentistry and medicine," said Dan Hosler, CEO of Allied OMS.
  • Facial & Oral Surgery Associates marks the sixth Texas practice in the Allied OMS family, expanding access to care to tens of thousands of patients throughout the state.
  • Headquartered in Southlake, Texas, Allied OMS has a total of nine partner practices serving patients out of 13 locations across Texas, Colorado, and California.
  • Facial and Oral Surgery Associates provides oral and maxillofacial surgical care in Fort Worth, Arlington, Weatherford, and surrounding areas.

U.S. Dermatology Partners is pleased to welcome Dermatologist Aaron Fong, M.D., to their Sterling, Virginia location

Monday, October 4, 2021 - 8:00am

STERLING, Va., Oct. 4, 2021 /PRNewswire-PRWeb/ --U.S Dermatology Partners is pleased to welcome Dermatologist Dr. Aaron Fong to their Sterling, Virginia location.

Key Points: 
  • STERLING, Va., Oct. 4, 2021 /PRNewswire-PRWeb/ --U.S Dermatology Partners is pleased to welcome Dermatologist Dr. Aaron Fong to their Sterling, Virginia location.
  • Dr. Fong served as Chief Resident in his final year of residency in Washington, D.C. at George Washington University.
  • Dr. Fong chose dermatology because it offers a wide variety of conditions to be seen and treated in clinic.
  • Dr. Fong treats patients in Sterling, Virginia at U.S. Dermatology Partners and is accepting new patients.